Login / Signup

In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking.

Jiao-Long WangLiang LiMei-Bian HuBo WuWen-Xiang FanWei PengDa-Neng WeiChun-Jie Wu
Published in: Comput. Biol. Chem. (2019)
Keyphrases